MSI2 and B-cell chronic lymphocytic leukemia: To verify these results, we simultaneously studied MSI2 levels in 55 CLL patients (Table S1A) and 25 HDs by flow cytometry, documenting that CLL cells display higher levels of MSI2 protein than HD B cells of both the CD5+ and CD5− subsets (Fig. 1A).